Labour force participation among individuals with hepatitis C in the US

PharmacoEconomics

Volumn 21, Issue 8, 2003, Pages 565-572

  Jacobs, Philip ^a,c   Chu Ng, Ying ^b   Stafinski, Tania ^c   Dodd, Roger ^d   Larke, Bryce ^e   Wong, Winnie ^a  

^a UNIVERSITY OF ALBERTA   (Canada)

^b HONG KONG BAPTIST UNIVERSITY   (Hong Kong)

^c INSTITUTE OF HEALTH ECONOMICS   (Canada)

^d HOLLAND LABORATORY   (United States)

^e Yukon Medical Office of Health   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE;

ADULT; AGED; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; CONTROLLED STUDY; DEMOGRAPHY; DISEASE ASSOCIATION; ECONOMIC ASPECT; EMPLOYMENT; FEMALE; GENDER; HEALTH SURVEY; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; MAJOR CLINICAL STUDY; MALE; MORBIDITY; OUTCOMES RESEARCH; PRIORITY JOURNAL; SOCIAL ASPECT; UNITED STATES;

ADOLESCENT; ADULT; AGED; ALANINE TRANSAMINASE; FEMALE; HEPATITIS C; HEPATITIS C ANTIBODIES; HUMANS; MALE; MIDDLE AGED; MODELS, ECONOMIC; UNEMPLOYMENT; UNITED STATES;

EID: 0037495970     PISSN: 11707690     EISSN: None     Source Type: Journal    
DOI: 10.2165/00019053-200321080-00003     Document Type: Article

References (21)

1. Recommendations for prevention and control of hepatitis C virus (HCV) infection and HCV-related chronic disease. MMWR Morb Mortal Wkly Rep 1998; 47 (RR-19): 1-39
2. Alter HJ, Seeff LB. Recovery, persistence, and sequelae in hepatitis C virus infection: a perspective on long-term outcome. Semin Liver Dis 2000; 20: 17-35
3. Tailor S. Hepatitis C: a review [online]. Available from URL: http://www.pharmacyconnects.com/content/phpractice/2000/10-00/ce-10.pdf [Accessed 2003 Aprl6]
4. Alter MJ, Kruszon-Moran D, Nainan OV, et al. The prevalence of hepatitis C virus infection in the United States, 1988 through 1994. N Engl J Med 1999; 341: 556-62
5. Wong JB, McQuillan GM, McHutchison JG, et al. Estimating future hepatitis C morbidity, mortality, and costs in the United States. Am J Public Health 2000; 90: 1562-9
6. Summary of notifiable diseases, United States, 1998. MMWR Morb Mortal Wkly Rep 1999; 47 (53): 1-93
7. Dusheiko GM, Roberts JA. Treatment of chronic type B and C hepatitis with interferon alfa: an economic appraisal. Hepatology 1995; 22: 1863-73
8. Shiell A, Law MG. The cost of hepatitis C and the cost-effectiveness of its prevention. Health Policy 2001; 58 (2): 121-31
9. Leigh JP, Bowlus CL, Leistikow BN, et al. Costs of hepatitis C. Arch Intern Med 2001; 161: 2231-7
10. Bowen W, Finegan T. The economics of labor force participation. Princeton (NJ): Princeton University Press, 1969
11. Heckman J. Shadow prices, market wages, and labor supply. Econometrica 1974; 42 (4): 679-94
12. Bound J, Schoenbaum M, Waidmann T. Race and education differences in disability status and labor force attachment in the health and retirement survey. J Hum Resour 1995; 30 Suppl.: S227-67
13. Welch F. Wages and participation. J Labor Econ 1997; 15 (1 Pt 2): S77-S103
14. Kidd MP, Solane, PJ, et al. Disability and the labour market: an analysis of British males. J Health Econ 2000; 19 (6): 961-81
15. Goldberger AS. Econometric theory. New York: Wiley, 1964
16. Maddala GS. Limited-dependent and qualitative variables in econometrics. Cambridge: Cambridge University Press, 1983
17. Greene WH. Econometric analysis. 4th ed. Upper Saddle River (NJ): Prentice Hall, 2000
18. Gopal DV, Rosen HR. Abnormal findings on liver function tests. Interpreting results to narrow the diagnosis and establish a prognosis. Postgrad Med 2000; 107: 100-2, 105-9, 113-4
19. Thomas DL, Astemborski J, Rai RM, et al. The natural history of hepatitis C virus infection: host, viral, and environmental factors. JAMA 2000; 284: 450-6
20. Rones PL, Ilg RE, Gardner JM. Trends in hours of work since the mid-1970s. Mon Labor Rev 1997; 120 (4): 3-14
21. Alter MJ, Kruszon-Moran D, Nainan OV, et al. The prevalence of hepatitis C virus infection in the United States, 1988 through 1994. N Engl J Med 1999; 341: 556-62